Healthcare

Clover Health & Onconova Therapeutics: Two Rising Healthcare Stocks
May 18, 2021 04:13 AM AEST| By Team Kalkine MediaSummary Clover Health posted record revenue growth of US$200.3 million in Q1 of 2021. The stock of Onconova jumped 13.82% from its previous close to US$0.5987 at 11:50 am ET on May 17, ahead of its quarterly earnings report. Technology-based h.....

BioNTech Stock Jumps 10% After Strong Earnings Report
May 11, 2021 10:18 AM AEST| By Team Kalkine MediaSummary German biotechnology firm BioNTech’s revenues rose to €2.05 billion (US$2.49 billion) in the first quarter of 2021, compared to €27.7 million in the year-ago period. The stock gained more than 310% in the past 12 months,.....

Why These Three Penny Health Stocks Skyrocket Today?
May 05, 2021 05:20 AM AEST| By Team Kalkine MediaSummary Cocrystal stock (NASDAQ: COCP) jumped over 147% to US$3.07 at 12:21 pm ET on Tuesday, May 4. BioLineRx stock (NASDAQ:BLRX) soared over 68% to US$5.35 at 1:20 pm ET. Precipio stock (NASDAQ:PRPO) surged 15.52% to US$5.7181 at 2:47 pm ET......

Will These Three Healthcare Stocks Double In 2021?
May 04, 2021 05:35 AM AEST| By Team Kalkine MediaThe pandemic has triggered a flurry of activities in the pharmaceutical sector as companies rush to develop drugs to combat the virus. Following the early stage of drug development, companies are coming up with new medicines that are proving effect.....

Five Healthcare Stocks That May Benefit From Biden’s Drug Policy
April 29, 2021 03:19 AM AEST| By Team Kalkine MediaSummary President Biden’s new drug policy gets huge support from lawmakers, cutting across political lines. The policy allows the export of essential medicines and raw materials to friendly countries. US drugmakers are expected to receiv.....

2 COVID Vaccine Stocks to Watch In 2021
April 10, 2021 09:52 AM AEST| By Team Kalkine MediaSource:solarseven, Shutterstock Summary Moderna anticipates US$18.4 billion in sales from its COVID-19 vaccines in 2021. Pfizer forecasts COVID-19 vaccine revenue in 2021 to hit US$15 billion. Moderna’s stock skyrocketed over 430 percen...